1. Class action lawsuit against Sarepta for federal securities law violations. 2. Allegations of misleading statements regarding ELEVIDYS therapy safety and approval potential. 3. Investors misled on revenue outlook for ELEVIDYS, impacting market confidence. 4. Shareholders between June 22, 2023, and June 24, 2025, may be affected.
Lawsuits and allegations of misleading statements can significantly harm investor confidence. Historical cases, such as those involving Theranos, illustrate potential for drastic share price drops due to legal issues.
Legal troubles can lead to significant shifts in stock price and investor sentiment; high likelihood of immediate impact on SRPT. The ongoing lawsuit highlights serious concerns for investors, affecting overall market confidence.
Market reactions to legal news tend to be immediate, often impacting stock prices quickly. Investors may sell shares amid uncertainty, causing rapid declines.
The DJS Law Group reminds investors of a class action lawsuit against Sarepta Therapeutics, Inc. ("Sarepta" or "the Company") (NASDAQ: SRPT) for violations of the federal securities laws.
Shareholders who purchased the Company's securities between June 22, 2023 and June 24, 2025, inclusive (the "Class Period"), are encouraged to contact the firm before August 25, 2025.
The complaint alleges that the Company made false and misleading statements to the market concerning Sarepta leading investors to believe that its ELEVIDYS therapy was both safe and had potential for approval in wider applications. The Company allegedly misled the market about its revenue outlook on ELEVIDYS. The Company also positioned the therapy as having strong growth potential due to a lack of hindrances to broader use.
If you are a shareholder who suffered a loss, contact us to participate.
DJS Law Group's primary focus is to enhance investor return through balanced counseling and aggressive advocacy. We specialize in securities class actions, corporate governance litigation, and domestic/international M&A appraisals. Our clients are some of the largest and most sophisticated hedge funds and alternative asset managers in the world. The litigation claims of our clients are extraordinarily valuable assets that demand respect, focus, and results.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
David J. Schwartz
DJS Law Group
274 White Plains Road, Suite 1
Eastchester, NY 10709
Phone: 914-206-9742
Email: [email protected]
SOURCE DJS Law Group LLP